Table 2.
Overall | Male | Female | p-value | |
---|---|---|---|---|
Preoperative SSA | 56/65 | 18/22 | 39/43 | 0.427 |
Short-term SSA | 30 | 6 | 25 | 0.054 |
Long-term SSA | 26 | 12 | 14 | |
No use of SSA | 9 | 5 | 4 | |
Medication time (short-term)/weeks (n = 29) |
1.4 (1.0, 2.0) | 1.35 (0.55, 2.23) | 1.4 (1.0, 2.0) | 0.854 |
Medication time (long-term)/weeks (n = 26) |
12.0 (8.0, 14.13) | 12.0 (5.75, 13.13) | 12.0 (11.0, 16.0) | 0.462 |
Time for hormonal control (short-term)/days (n = 22) |
2.5 (2.0, 5.25) | 2.0 (1.0, 4.0) | 3.0 (2.0, 6.0) | 0.249 |
Time for hormonal control (long-term)/weeks (n = 16) |
4.0 (1.0, 8.5) | 4.0 (1.0, 10.0) | 4.0 (1.0, 4.0) | 0.536 |
Somatostatin receptor scintigraphy (+) | 40/53 | 13/17 | 27/36 | 1.00 |